Endymed Ltd

TASE:ENDY Voorraadrapport

Marktkapitalisatie: ₪30.4m

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Endymed Beheer

Beheer criteriumcontroles 3/4

Endymed's CEO is Yossi Bar-On, appointed in Mar 2017, has a tenure of 7.58 years. total yearly compensation is $287.00K, comprised of 99.3% salary and 0.7% bonuses, including company stock and options. directly owns 0.53% of the company’s shares, worth ₪160.05K. The average tenure of the management team and the board of directors is 5.1 years and 2.3 years respectively.

Belangrijke informatie

Yossi Bar-On

Algemeen directeur

US$287.0k

Totale compensatie

Percentage CEO-salaris99.3%
Dienstverband CEO7.6yrs
Eigendom CEO0.5%
Management gemiddelde ambtstermijn5.1yrs
Gemiddelde ambtstermijn bestuur2.3yrs

Recente managementupdates

Recent updates

Endymed Ltd's (TLV:ENDY) 25% Dip In Price Shows Sentiment Is Matching Revenues

Sep 23
Endymed Ltd's (TLV:ENDY) 25% Dip In Price Shows Sentiment Is Matching Revenues

Endymed Ltd (TLV:ENDY) Investors Are Less Pessimistic Than Expected

Aug 06
Endymed Ltd (TLV:ENDY) Investors Are Less Pessimistic Than Expected

Here's What's Concerning About Endymed's (TLV:ENDY) Returns On Capital

May 24
Here's What's Concerning About Endymed's (TLV:ENDY) Returns On Capital

Endymed Ltd's (TLV:ENDY) Share Price Not Quite Adding Up

Mar 11
Endymed Ltd's (TLV:ENDY) Share Price Not Quite Adding Up

Endymed (TLV:ENDY) Is Looking To Continue Growing Its Returns On Capital

Oct 23
Endymed (TLV:ENDY) Is Looking To Continue Growing Its Returns On Capital

We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)

Jul 17
We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)

Returns Are Gaining Momentum At Endymed (TLV:ENDY)

Apr 03
Returns Are Gaining Momentum At Endymed (TLV:ENDY)

Endymed's (TLV:ENDY) Returns On Capital Are Heading Higher

Nov 18
Endymed's (TLV:ENDY) Returns On Capital Are Heading Higher

We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)

Jun 03
We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)

Endymed (TLV:ENDY) Is Doing The Right Things To Multiply Its Share Price

Feb 13
Endymed (TLV:ENDY) Is Doing The Right Things To Multiply Its Share Price

Here's Why We Think Endymed (TLV:ENDY) Is Well Worth Watching

Nov 28
Here's Why We Think Endymed (TLV:ENDY) Is Well Worth Watching

Endymed (TLV:ENDY) Is Experiencing Growth In Returns On Capital

Oct 31
Endymed (TLV:ENDY) Is Experiencing Growth In Returns On Capital

Is Now The Time To Put Endymed (TLV:ENDY) On Your Watchlist?

Aug 29
Is Now The Time To Put Endymed (TLV:ENDY) On Your Watchlist?

Investors Will Want Endymed's (TLV:ENDY) Growth In ROCE To Persist

Aug 01
Investors Will Want Endymed's (TLV:ENDY) Growth In ROCE To Persist

We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)

Apr 11
We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)

Endymed Ltd's (TLV:ENDY) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Feb 15
Endymed Ltd's (TLV:ENDY) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Returns On Capital - An Important Metric For Endymed (TLV:ENDY)

Jan 10
Returns On Capital - An Important Metric For Endymed (TLV:ENDY)

Should You Use Endymed's (TLV:ENDY) Statutory Earnings To Analyse It?

Dec 14
Should You Use Endymed's (TLV:ENDY) Statutory Earnings To Analyse It?

Analyse CEO-vergoeding

Hoe is Yossi Bar-On's beloning veranderd ten opzichte van Endymed's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

-US$835k

Mar 31 2024n/an/a

-US$437k

Dec 31 2023US$287kUS$285k

US$553k

Sep 30 2023n/an/a

US$773k

Jun 30 2023n/an/a

US$998k

Mar 31 2023n/an/a

US$907k

Dec 31 2022US$328kUS$316k

US$850k

Sep 30 2022n/an/a

US$3m

Jun 30 2022n/an/a

US$4m

Mar 31 2022n/an/a

US$5m

Dec 31 2021US$434kUS$321k

US$5m

Sep 30 2021n/an/a

US$2m

Jun 30 2021n/an/a

US$2m

Mar 31 2021n/an/a

US$838k

Dec 31 2020US$268kUS$266k

US$308k

Compensatie versus markt: Yossi's total compensation ($USD287.00K) is below average for companies of similar size in the IL market ($USD429.66K).

Compensatie versus inkomsten: Yossi's compensation has been consistent with company performance over the past year.

CEO

Yossi Bar-On (56 yo)

7.6yrs

Tenure

US$287,000

Compensatie

Mr. Yossi Bar-On, CPA has been the Chief Executive Officer of Endymed Ltd. since March 22, 2017. Mr. Bar-On served as the Chief Financial Officer since July 2014 and Chief Operating Officer at Sanara Ventu...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Yossi Bar-On
Chief Executive Officer7.6yrsUS$287.00k0.53%
$ 160.1k
Rami Aviram
Chief Financial Officer6.3yrsUS$204.00kgeen gegevens
Amir Ganun
Vice President of International Sales & Marketing4.3yrsUS$279.00kgeen gegevens
Bill Scott
President of Endymed Inc.2.5yrsUS$352.00kgeen gegevens
Sima Weissman
Vice President of Research & Development5.9yrsUS$144.00kgeen gegevens
Asaf Nachmanovich
Chief Operating Officer1.8yrsgeen gegevensgeen gegevens

5.1yrs

Gemiddelde duur

53yo

Gemiddelde leeftijd

Ervaren management: ENDY's management team is seasoned and experienced (5.1 years average tenure).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Gilai Dolev
Independent External Director2.3yrsgeen gegevensgeen gegevens
Ofer Zvi
Director6.8yrsgeen gegevensgeen gegevens
Tal Rubinstein
Independent External Director2.3yrsgeen gegevensgeen gegevens
Ariel Rubashkin
Independent Director3.8yrsgeen gegevensgeen gegevens
Xiu Yang
Director1.9yrsgeen gegevensgeen gegevens

2.3yrs

Gemiddelde duur

50yo

Gemiddelde leeftijd

Ervaren bestuur: ENDY's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.